BRIEF REPORTS
Effects of Care Management and Telehealth: A Longitudinal
Analysis Using Medicare Data
† †
Laurence C. Baker, PhD,* Dendy S. Macaulay, PhD, Rachael A. Sorg, MPH,
† ‡ ‡
Melissa D. Diener, BS, Scott J. Johnson, PhD, and Howard G. Birnbaum, PhD
OBJECTIVES: To evaluate mortality and healthcare utili- fewer admissions for individuals with chronic obstructive
zation effects of an intervention that combined care man- pulmonary disease and mortality for those with congestive
agement and telehealth, targeting individuals with heart failure.
congestive heart failure, chronic obstructive pulmonary CONCLUSION: Care management coupled with content-
disease, or diabetes mellitus. driven telehealth technology has potential to improve
DESIGN: Retrospective matched cohort study. health outcomes in high-cost Medicare beneficiaries. J Am
SETTING: Northwest United States. Geriatr Soc 61:1560–1567, 2013.
PARTICIPANTS: High-cost Medicare fee-for-service ben-
eficiaries (N = 1,767) enrolled in two Centers for Medicare Key words: telehealth; electronic communication; care
and Medicaid Services demonstration participating clinics management
and a propensity-score matched control group.
INTERVENTION: The Health Buddy Program, which
integrates a content-driven telehealth system with care
management.
MEASUREMENTS: Mortality, inpatient admissions, hos- Chronic diseases are associated with considerable mor-
pital days, and emergency department (ED) visits during
bidity, mortality, and costs, and managing them well
the 2-year study period were measured. Cox-proportional is of considerable interest.1 Barriers to effective manage-
hazard models and negative binomial regression models
ment can arise because of coordination and communica-
were used to assess the relationship between the interven-
tion gaps when individuals have multiple providers of
tion and survival and utilization, controlling for demo-
care.2 Better disease management may be a way to address
graphic and health characteristics that were statistically
this challenge. The Centers for Medicare and Medicaid
different between groups after matching.
Services (CMS) has sponsored several demonstration pro-
RESULTS: At 2 years, participants offered the Health
jects emphasizing disease management for chronically ill
BuddyProgramhad15%lowerrisk-adjustedall-causemor- Medicare recipients,3,4 that provide important opportuni-
tality (hazard ratio (HR) = 0.85, 95% confidence interval
ties to investigate the effect of better disease management
(CI) = 0.74–0.98; P = .03) and had reductions in the num-
on health outcomes. One demonstration project examined
ber of quarterly inpatient admissions from baseline to the
the Health Buddy Program (HBP), which integrates care
study period that were 18% greater than those of matched
management with the Health Buddy device, a telehealth
controls during this same time period ((cid:1)0.035 vs (cid:1)0.003;
device located in an individual’s home and linked over the
difference-in-differences = (cid:1)0.032, 95% CI = (cid:1)0.054 to
telephone, to care managers to facilitate information
(cid:1)0.010, P = .005). No relationship was found between
exchange. The current study analyzed the effect of the
the Health Buddy Program and ED use or number of hos-
HBP on healthcare utilization and mortality.
pital days for participants who were hospitalized. The
Previous evaluations have considered care manage-
Health Buddy Program was most strongly associated with
ment and telehealth programs separately and reported
mixed
results.5–10
Approaches integrating information
technology tools with care management appear promising
Fromthe*StanfordUniversity,Stanford,California;†AnalysisGroup,
Inc.,NewYork,NewYork;and‡AnalysisGroup,Inc.,Boston, but are less well studied. Previous analyses have found an
Massachusetts. association between the HBP, lower costs, and longer
survival in Medicare beneficiaries,11,12 and benefits of HBP
AddresscorrespondencetoLaurenceBaker,RedwoodBldg,RmT110,
StanfordUniversity,Stanford,CA94305.E-mail:Laurence. in a Veterans Affairs setting.13,14
baker@stanford.edu In contrast to prior publications, this article focuses
DOI:10.1111/jgs.12407 on mortality and healthcare utilization effects, particularly
JAGS 61:1560–1567,2013
©2013,CopyrighttheAuthors
Journalcompilation©2013,TheAmericanGeriatricsSociety 0002-8614/13/$15.00
JAGS SEPTEMBER2013–VOL. 61, NO. 9 EFFECTSOFCAREMANAGEMENTANDTELEHEALTH 1561
hospitalizations and emergency department (ED) visits. inpatient admissions, hospital days for those admitted,
Hospitalizations are of interest because they can amplify and ED visits, by comparing the intervention group with
morbidity and age-related physiological changes. Hospital- a propensity-matched control group. An intention-to-treat
ization itself poses risks to elderly adults because of lack approach was used, considering all participants offered
of mobility, lower activity levels, and iatrogenic risks.15 HBP as the intervention group, regardless of whether they
used it. Approximately 37% of the intervention popula-
tion inputted information into the system at least once
METHODS
(“engaged” the system). Engaged participants used Health
Buddy for 300 days during the demonstration, on aver-
The Intervention
age.
The Health Buddy device is a small electronic device with Changes in utilization measures for the intervention
a high-resolution screen and four large buttons designed to and control participants from a 1-year period before
easily collect information from individuals regarding their the intervention was offered (baseline) were compared
symptoms, vital signs, mental health, knowledge, and with a 2-year period afterward (study period). Hazard
health behaviors. Participants received daily questions models were used to study differences in survival for
related to their diagnoses (e.g., “Do you have more short- the intervention and control groups during the study
ness of breath than usual today?”) and responded using the period.
buttons. Responses were uploaded to a software system
accessible over a secure Web portal that risk-stratified
Data Sources and Matching Controls
responses to support daily care manager review. The sys-
tem identified the need for intervention based on signals Data for intervention participants came from finalized
such as deteriorating clinical signs (e.g., shortness of breath Medicare claims that CMS provided from the demonstra-
at all times vs with activity), lack of response, or gaps in tion project. Control data came from Medicare claims
individuals’ knowledge and behaviors, potentially improv- from a 5% random sample of all beneficiaries (CMS 5%
ing coordination of appropriate services and contact with sample).16 Mortality (date of death) was observable from
providers.12 It also provided appropriate feedback and edu- enrollment files linked to Social Security Administration
cational information to individuals about their condition death records.
that may have improved self-care (e.g., “Call your doctor To construct the propensity-matched control group,
today to report your increased shortness of breath” or “Be Pacific Northwest counties similar to Bend and
sure to take rest breaks in between your routine activities. Wenatchee in terms of demographic characteristics and
This is called activity pacing. If this increased shortness of hospital markets (control county selection criteria avail-
breath continues, call your doctor to report it”). able upon request) 17 were identified, and Medicare bene-
The HBP demonstration project was implemented at ficiaries in the CMS 5% sample residing in those areas
two multispecialty clinics located in Bend, Oregon, and were selected. Propensity-score matching was then used
Wenatchee, Washington. The demonstration targeted indi- to select beneficiaries who most resembled intervention
viduals with congestive heart failure (CHF), chronic participants18 using probit regression models for each
obstructive pulmonary disease (COPD), or diabetes mel- cohort. Being offered HBP was the dependent variable,
litus (DM).12 To select intervention participants, beneficia- and demographic characteristics, diagnoses, Medicare
ries residing in a county that the two clinics primarily Hierarchical Condition Category (HCC) risk scores,19
served were identified from Medicare records. A selection and baseline utilization were independent variables. Con-
algorithm then identified participants with the targeted trol and intervention participants were matched 1:1 with
conditions who were loyal to a study clinic (had ≥2 visits replacement based on closest propensity scores, requiring
at the clinic or received more care from the clinic than any scores within 0.01. A sufficiently close match could not
other). The algorithm selected only those who were not in be found for 52 intervention participants, and they were
hospice, did not have conditions that would limit interac- excluded (propensity score distribution available upon
tion with HBP or its effectiveness (e.g., dementia, blind- request).
ness), or had high-cost conditions unlikely to be affected
by HBP, such as end-stage renal disease. A full list of tar-
Measurements
get exclusionary comorbidities is available upon request.
Demonstration participants were selected at two time Mortality was based on validated date of death. Quarterly
points. The first cohort comprised 763 beneficiaries identi- measures of the number of inpatient admissions, hospital
fied in early 2006. The second cohort consisted of 1,056 days for those admitted, and ED visits were constructed
beneficiaries identified in early 2007 to expand the study for each beneficiary. Quarters (3-month intervals) for
and account for attrition. Care managers from each clinic intervention participants were aligned to match the Febru-
contacted and invited selected participants over a period of ary 1 start date of the intervention. Participant age and
several months beginning in February 2006 and 2007 for sex and presence of CHF, COPD, or DM were coded
the first and second cohorts, respectively. based on information available in claims data. Other com-
orbidities were used to construct the Elixhauser index,20
excluding CHF, COPD, and DM because they were
Analytical Overview
included in the matching model. Disease conditions were
This project examined the relationship between the HBP identified based on diagnosis codes using Medicare claims
and mortality and healthcare utilization, including (codes available upon request).
1562 BAKERETAL. SEPTEMBER2013–VOL. 61, NO. 9 JAGS
Statistical Analysis Mortality
SAS 9.2 (SAS Institute, Inc,. Cary, NC) and Stata 10.1 Health Buddy Program was associated with lower risk of
(StataCorp, College Station, TX) were used for analyses. mortality in unadjusted survival analysis (P = .01)
Unadjusted survival rates in the study period were (Figure 1). In Cox proportional hazard models, HBP was
evaluated using Kaplan-Meier curves and log-rank tests. associated with a 15% lower risk-adjusted probability of
Toadjustfor potential differences in participant characteris- death (Hazard ratio (HR) = 0.85, 95% CI = 0.74–0.98,
tics, Cox proportional hazard models were used, in which P = .03). Subgroup analyses found that the lower proba-
the dependent variable was time from the first day of HBP bility of death was largest in individuals with CHF
availability until death or the end of the study period, (HR = 0.70, 95% CI = 0.57–0.85, P < .001) and engaged
controlling for demographic and health characteristics participants (HR = 0.52, 95% CI = 0.39–0.68, P < .001).
from the propensity-score matching algorithm that were
statistically different between the groups after matching
Healthcare Utilization
(P < .10) (full regression results available upon request).
UtilizationwasstudiedusingtheyearbeforeHBPbegan In the intervention group, there were an average of 0.179
as a baseline and comparing changes in utilization over the admissions per quarter during baseline and 0.144 in the
study period.13 Utilization analyses presented here include study period, a reduction of 0.035 per member per quarter
onlyquartersinwhichtheparticipantwasaliveandenrolled (Table 2). Average quarterly hospitalizations for the con-
in Medicare Part A and B for the wholequarterand exclude trol group decreased by 0.002 visits per member per quar-
quarters immediatelybefore and after HBP became available ter, suggesting a net decline of 0.032 (18%) associated
to account for uncertainty in the effective intervention start with HBP (95% CI = (cid:1)0.054 to (cid:1)0.010, P = .005) and a
time.12 For participants who died, the utilization analyses number needed to treat to avoid one hospitalization per
alsoexcludeddatafromthequarterofdeath. Inmultivariate quarter of 32 participants. No significant relationship was
analyses, panel negative binomial models in which the found for quarterly number of hospital days conditional
dependent variable was quarterly utilization were used. on hospitalization or for ED visits.
Important explanatory variables were intervention status, a Adjusted results for hospitalizations were consistent
study period indicator, and the interaction of these two with univariate findings, with a decline of 0.034 more in
indicators. The models also controlled for relevant demo- the intervention group than in controls (95%
graphic and health characteristics. Results from the model CI = (cid:1)0.057 to (cid:1)0.016, P < .001) (Table 2). Addition-
were used to compute predicted quarterly utilization esti- ally, the differences in reductions between inpatient
mates, holding control characteristics fixed at their sample admissions of participants with COPD and engaged par-
means. Statistical significance was determined using t-tests ticipants and the reductions of their matched controls
forcontinuousvariables, chi-squaretestsforcategoricalvari- (COPD subgroup, P = .03; engaged subgroup, P = .003)
ables in univariate analysis, and bootstrapped confidence were larger than difference in reductions between the
intervals(CIs) forthe multivariate predictions.21 overall intervention group and the reductions of their
matched controls.
Subgroup Analyses
Sensitivity Analysis
All members of the intervention group were initially ana-
lyzed regardless of their active participation in the program. Results were similar when additional quarters were
Results for participants who ever used the system (engaged) included. Including the two quarters surrounding program
and those who never did (non-engaged) were compared sep- implementation resulted in an estimated net reduction of
arately with those of controls with closest propensity-score 0.018 (95% CI = (cid:1)0.037 to 0.001, P = .06) in average
matches. Separate models were used to explore the interven- quarterly admissions. Including the quarter of death for
tion and control group members with each targeted health participants who died resulted in an estimated reduction
condition because these conditions are diverse, and the sys- of 0.035 admissions (95% CI = (cid:1)0.057 to (cid:1)0.014,
tem may have influenceddisease groups differently. P = .001).
Utilization and Cox proportional hazard model results
using matching without replacement (n = 1,480 HBP and
Sensitivity Analyses
1,480 control participants) were generally consistent with
Sensitivity analyses were performed including quarters sur- the main analyses. Although the lower mortality trend was
rounding program implementation and including the quar- statistically insignificant in the overall sample (HR = 0.88,
ter of death for participants who died. Whether the use of 95% CI = 0.74–1.03, P = .11), the lower mortality associ-
propensity-score matching with replacement biased find- ated with HBP in the subgroup with CHF (HR = 0.71,
ings was also investigated by creating another control 95% CI = 0.56–0.91, P = .006) and the engaged subgroup
group using matching without replacement. (HR = 0.47, 95% CI = 0.34–0.65, P < .001) was still evi-
dent. Matching without replacement was not the preferred
approach because it reduced the precision of matches,
RESULTS
potentially accounting for the higher P-value, although
Participant demographics and clinical characteristics were similarity of the estimates confirmed that matching some
similar between intervention (n = 1,767) and matched control observations multiple times did not drive the main
control (n = 1,767) participants (Table 1). result.
JAGS SEPTEMBER2013–VOL. 61, NO. 9 EFFECTSOFCAREMANAGEMENTANDTELEHEALTH 1563
Table 1 (Contd.)
Table 1. Baseline Demographic and Clinical Charac-
teristics
Intervention, Control,
Intervention, Control, Characteristic n=1,767 n=1,767 P-Valuea
Characteristic n=1,767 n=1,767 P-Valuea
Carriervisits 38.57 38.95 .18
Demographic Durablemedical 9.04 9.00 .36
Age,mean 76.8 76.7 .54 equipmentclaims
Male,% 53.7 52.5 .50 ≥1hospicevisits,% 0.6 1.1 .09
Aged<65,% 7.4 6.7 .47
Baselinecomorbidities,%b CHF=congestiveheartfailure;DM=diabetesmellitus.
Primarydiseasesofinterest aUnivariatecomparisonsofcentraltendenciesusedWilcoxontestsforcon-
CHF 35.8 37.7 .22 tinuousvariablesandchi-squaretestsforcategoricalvariables.
DM 50.0 53.0 .07 bBaseline comorbidities were diagnosed based upon at least two claims
Chronicobstructive 35.7 38.2 .13 with the related International Classification of Diseases, Ninth Revision,
pulmonarydisease codes,excludinglaboratoryorradiologyclaims.
SequelaeofCHF:Arrhythmia 24.8 23.4 .33
SequelaeofDM
Neurologicalsymptoms 15.6 16.0 .75 DISCUSSION
Peripheralvasculardisease 21.8 22.8 .49
The growing prevalence of chronic conditions poses chal-
Cardiovasculardisease 80.1 82.5 .08
Ischemicheartdiseases 24.9 28.9 .008 lenges to the healthcare system. This study evaluated an
Renalcomplications 22.8 23.8 .47 intervention integrating telehealth with care management
Endocrineand 27.1 25.1 .17 in participants with chronic disease. Two-year mortality
metaboliccomplications for HBP was 15% lower than propensity score–matched
Ophthalmiccomplications 29.9 29.9 >.99 controls, and admissions were 18% lower, but an effect
Othercomplications 12.7 12.6 .88
on ED visits and hospital days was not found.
Othercomorbidities
This study was designed to investigate overall relation-
Hypertension 51.4 52.6 .50
ships between HBP, utilization, and mortality. It did not
Disordersoflipid 25.5 23.3 .12
metabolism provide sufficient data to identify underlying mechanisms
Diseasesofesophagus, 8.1 8.8 .51 for the observed effect, but several possibilities warrant
stomach,andduodenum further research. HBP includes components that could
Coronaryarterydisease 25.1 29.3 .005 facilitate improvements in self-management in areas
Hyperlipidemia 25.5 23.3 .12 including exercise, diet, medication adherence, and com-
Atrialfibrillation 21.2 19.7 .26 munication with providers.22 Use of HBP may lead partici-
Anemia 14.3 14.7 .74
pants to better understand their health conditions,
Chronickidneydisease 23.1 24.3 .41
improving self-care and reducing hospitalizations.23
Arthritis 26.4 26.0 .79
Cancer 13.2 14.7 .21 Health Buddy Program may also improve the ability
Skeletalmuscledysfunction 10.0 9.1 .33 of care managers to respond quickly to changes in patient
Respiratoryinfection 19.5 19.0 .67 conditions, which may be associated with better out-
Glaucoma 8.8 8.8 .95 comes.24 Some literature also links hospitalization itself
Overallhealthindicators with new and worsening geriatric health conditions 25 in
AdjustedElixhauser 1.68 1.71 .84 addition to a subsequent greater mortality risk.26,27 An
comorbidityindex,
intervention that reduces hospitalizations, as this interven-
mean
tion appears to do, may be able to reduce mortality
Hierarchicalconditions 2.28 2.38 .16
categoriesscore,mean through this mechanism.
End-stagerenaldisease,% 1.3 1.8 .22 These findings suggest that effects of HBP vary
Exclusionarycomorbidity,% 7.8 7.8 >.99 according to disease subgroup. Individuals with CHF expe-
Baselinecostquintile($),% rienced the strongest survival effect, consistent with previ-
1(<3,109) 20.6 18.9 .20 ous work showing an effect of remote telemonitoring
2(3,109–6,250) 20.4 19.9 .71 on mortality for individuals with CHF.28 The largest
3(6,251–12,293) 19.9 19.4 .70
4(12,294–25,000) 19.6 20.8 .38 reduction in hospitalizations was found for the COPD
5(≥25,000) 19.6 21.1 .26 subgroup. COPD is progressive; lung function typically
Resourceutilization, worsens over time even with the best available care.29
meannumber Pharmacotherapy is typically used to control symptoms
Inpatienthospitalvisits 0.64 0.71 .19 and reduce severity and frequency of exacerbations.29
Skillednursing 0.09 0.08 .001 Because exacerbations are the main cause of healthcare
facilityvisits utilization,30 it seems plausible that a care management
Outpatientvisits 12.72 11.83 <.001
program aimed at improving medication adherence and
Emergency 0.74 0.80 .08
timely access to care could reduce exacerbation-related
departmentvisits
healthcare utilization. In a subgroup analysis, participants
Homehealthvisits 0.20 0.22 .007
in the HBP group who engaged with the system at least
(Continued) one time had lower mortality and fewer hospital admis-
sions than the subset of the intervention group who never
1564 BAKERETAL. SEPTEMBER2013–VOL. 61, NO. 9 JAGS
Intervention, n=1,767 Intervention, n=884
Control, n=1,767 Control, n=937
Intervention, n=652 Intervention, n=631
Control, n=652 Control, n=675
Intervention, n=1,115 Intervention, n=632
Control, n=1,115 Control, n=667
Figure 1. Kaplan-Meier and Cox proportional hazard estimates for survival after baseline period. Kaplan Meier curves represent
unadjusted difference in survival between intervention and control participants, with P-values based on the test. Cox propor-
tional hazard ratios (HRs) and 95% confidence intervals (CIs) curves represent adjusted difference in survival between Interven-
tion and Control participants. Ties in event occurrence are treated using the exact method; a true, but unknown, ordering is
assumed to exist fortiedevent times(timeiscontinuous).
used the system. Although there may be selection effects in tify the intervention group and matched using propensity
this subgroup, these findings suggest an opportunity to score methods. Disease subgroups were also evaluated, and
increase participation and better target the HBP selection different analytical methods were employed in an attempt
toward particular groups of individuals who are most to account explicitly for time trends in utilization. The
likely to use the program and benefit from it. Future analy- conclusions also shared some similarities, notably the find-
ses could investigate this possibility. ings toward reductions in utilization and mortality for the
This study was conducted independently of a CMS- HBP group.
sponsored evaluation of the demonstration program.11 Previous evaluations of the effectiveness of telehealth
Although the approaches shared certain features, the cur- technologies have found mixed results. For example, a ran-
rent study used a different approach to select a control domized controlled trial comparing telemonitoring with
group with the CMS 5% sample. Specifically, the control usual care at the Mayo Clinic in older adults with multiple
group was based on the selection algorithm used to iden- health conditions found that telemonitoring was associated
JAGS SEPTEMBER2013–VOL. 61, NO. 9 EFFECTSOFCAREMANAGEMENTANDTELEHEALTH 1565
Table 2. Average Resource Use Comparison of Intervention and Control Participants
Intervention Control RelativeChange(95%ConfidenceInterval)
Resource Baseline Study Baseline Study Unadjustedb P-Valuea Adjustedc P-Valuea
Quarterlynumberofinpatientadmissionsd
Overall 0.179 0.144 0.171 0.169 (cid:1)0.032((cid:1)0.05to(cid:1)0.01) .005 (cid:1)0.034((cid:1)0.06to(cid:1)0.02) <.001
DM 0.191 0.151 0.206 0.175 (cid:1)0.010((cid:1)0.04to0.02) .56 (cid:1)0.024((cid:1)0.05to0.01) .12
COPD 0.216 0.178 0.220 0.225 (cid:1)0.042((cid:1)0.08to(cid:1)0.001) .045 (cid:1)0.044((cid:1)0.08to(cid:1)0.003) .03
CHF 0.218 0.165 0.277 0.239 (cid:1)0.016((cid:1)0.06to0.03) .45 (cid:1)0.028((cid:1)0.07to0.01) .21
EngagedHealthBuddy 0.177 0.131 0.187 0.182 (cid:1)0.041((cid:1)0.08to(cid:1)0.004) .03 (cid:1)0.048((cid:1)0.09to(cid:1)0.02) .003
Non-engaged 0.180 0.152 0.162 0.161 (cid:1)0.026((cid:1)0.05to0.002) .07 (cid:1)0.027((cid:1)0.06to0.002) .07
Hospitaldaysperquarter,conditionalonhospitalizatione
Overall 4.765 5.829 5.402 6.845 (cid:1)0.378((cid:1)1.29to0.53) .42 (cid:1)0.244((cid:1)0.92to0.28) .29
DM 4.530 5.968 5.442 7.442 (cid:1)0.563((cid:1)1.81to0.68) .38 (cid:1)0.018((cid:1)0.93to0.60) .66
COPD 5.067 5.735 5.488 7.370 (cid:1)1.214((cid:1)2.63to0.20) .09 (cid:1)0.742((cid:1)1.66to0.06) .07
CHF 5.073 6.039 5.870 7.490 (cid:1)0.654((cid:1)2.17to0.86) .40 (cid:1)0.192((cid:1)1.16to0.82) .73
EngagedHealthBuddy 5.010 5.839 5.900 7.555 (cid:1)0.826((cid:1)2.44to0.79) .32 (cid:1)0.868((cid:1)2.08to0.01) .05
Non-engaged 4.623 5.824 5.082 6.400 (cid:1)0.118((cid:1)1.21to0.97) .83 0.084((cid:1)0.66to0.78) .88
Quarterlynumberofemergencydepartmentvisitsd
Overall 0.190 0.185 0.192 0.175 0.011((cid:1)0.02to0.04) .41 0.007((cid:1)0.02to0.03) .53
DM 0.209 0.194 0.230 0.185 0.031((cid:1)0.01to0.07) .12 0.022((cid:1)0.02to0.06) .27
COPD 0.230 0.230 0.257 0.217 0.041((cid:1)0.01to0.09) .12 0.021((cid:1)0.03to0.08) .32
CHF 0.211 0.187 0.266 0.222 0.020((cid:1)0.03to0.07) .43 0.017((cid:1)0.03to0.07) .38
EngagedHealthBuddy 0.158 0.162 0.204 0.186 0.021((cid:1)0.02to0.06) .30 0.011((cid:1)0.03to0.05) .54
Non-engaged 0.209 0.199 0.185 0.169 0.006((cid:1)0.03to0.04) .72 0.006((cid:1)0.03to0.04) .67
DM=diabetesmellitus;COPD=chronicobstructivepulmonarydisease;CHF=congestiveheartfailure.
aUnivariatecomparisonsofcentraltendenciesusedt-testsforcontinuousvariables.
bCalculated as (intervention sample study period outcome–intervention sample baseline period outcome)–(control sample study period outcome–control
samplebaselineperiodoutcome).
cPredictionswereestimatedusingpanelnegativebinomialmodels.ControlvariableswerethosecriteriawithP<.10aftermatching.
dQuarterlynumberofinpatientadmissionsandemergencydepartmentvisitswerecalculatedbasedontheaveragetotalnumberofclaimsforthatcategory
ineachquarter.
eHospitaldaysperquarterwascalculatedbasedontheclaimutilizationdaycountvariableandwasmeasuredconditionalonbeinghospitalized.
withsignificantlyhigherriskofmortalityandnonsignificantly to identifybeneficiariesrequiringattentionandcanintervene
higher rates of hospitalizations, ED visits, and total hospi- beforetheconditionworsens.
tal days.31 This study differed from the current one, which The main strength of this study was the use of statisti-
found that HBP was associated with significantly lower cal methods to compensate for the lack of a randomized
all-cause mortality for individuals with CHF and DM and control trial design. Propensity score–matching methods
nonsignificantly lower all-cause mortality for those with improved the balance in covariates between the two
COPD. It also found significantly fewer hospitalizations groups, and the difference-in-differences approach allowed
for individuals with COPD but nonsignificantly fewer for for the evaluation of an intervention effect while control-
those with CHF and DM. There are two important differ- ling for time-invariant unobservable factors.
ences between these studies that may have affected the The study had some limitations. First, the data did
outcomes. First, the Health Buddy is a different telehealth not contain clinical or sociodemographic information
system, which may lead to different associations with the (e.g., income or educational attainment) because claims
individual and outcomes. Second, participants were similar collected for administrative purposes were used. Any
at baseline in terms of demographics, comorbidities, and underlying differences in these characteristics could not
important resource utilization categories. Although partici- be controlled for and may have affected results. Addition-
pants randomized to telemonitoring or usual care at the ally, 5% Medicare data identify dates of services at the
Mayo Clinic had similar baseline characteristics, there quarter level, making analysis of readmissions impossible.
were substantially higher baseline rates of ED visits in the Second, the demonstration project was based on sole
telemonitoring group (73%) than with usual care (40%), community providers in the Pacific Northwest, potentially
suggesting that, despite randomization, there may be some limiting generalizability of these findings. In addition, this
underlying difference between the groups.31 study was designed to compare usual care with an inter-
By combining telehealth with care management, the vention that combined telehealth and care management.
HBP is interactive for individuals and care managers. This It did not attempt to demonstrate the added value of tele-
integrated approach may teach individuals to understand health over care management without telehealth. It also
their medical conditions and improve health behaviors. did not investigate different patterns of HBP use (e.g.,
Similarly, care managers with better information may be length and frequency of engagement) and the ways in
able to reinforce positive behavior by helping beneficiaries which these patterns affected outcomes. Further research
manage their conditions. Care managers may also be able into these areas is warranted. Like all studies based on
1566 BAKERETAL. SEPTEMBER2013–VOL. 61, NO. 9 JAGS
retrospective analysis of nonrandomized settings, this 5. Clark RA, Inglis SC, McAlister FA etal. Telemonitoring or structured
analysis could not prove causality with certainty. Addi- telephone support programmes for patients with chronic heart failure:
Systematicreviewandmeta-analysis.BMJ2007;334:942.
tional prospective studies would be valuable to further
6. ClelandJG,LewinterC,GoodeKM.Telemonitoringforheartfailure:The
verify the findings. only feasible option for good universal care? Eur J Heart Fail 2009;11:
These findings show that the availability of HBP was 227–228.
associated with fewer hospitalizations and longer survival 7. Inglis SC, Clark RA, McAlister FA etal. Structured telephone support or
telemonitoringprogrammesforpatientswithchronicheartfailure.Cochra-
in a group of Medicare beneficiaries with chronic disease
neDatabaseSystRev2010;(8):CD007228.
and suggest that integrated telehealth and disease manage- 8. Par(cid:1)eG,JaanaM,SicotteC.Systematicreviewofhometelemonitoringfor
ment could offer a valuable approach to improving care chronic diseases: The evidence base. J Am Med Inform Assoc 2007;
for high-cost Medicare beneficiaries with complex chronic
14:269–277.
9. ChaudhrySI,MatteraJA,CurtisJPetal.Telemonitoringinpatientswith
conditions.
heartfailure.NEnglJMed2010;363:2301–2309.
10. KoehlerF,WinklerS,SchieberMetal.Impactofremotetelemedicalman-
agement on mortality and hospitalizations in ambulatory patients with
ACKNOWLEDGMENTS
chronic heartfailure:The Telemedical InterventionalMonitoringinHeart
FailureStudy.Circulation2011;123:1873–1880.
The authors thank Kevin Brennan for database develop-
11. McCallN,CromwellJ,SmithKetal.EvaluationofMedicareCareMan-
ment support. agementforHighCostBeneficiaries(CMHCB)Demonstration:TheHealth
Conflict of Interest: Dendy S. Macaulay, Rachael Buddy Consortium (HBC), CMS Revised Final Report. Research Triangle
A. Sorg, Melissa D. Diener, and Howard G. Birnbaum are Park,NC:RTIInternational2011.
12. BakerL,JohnsonS,MacaulayDetal.Integratedtelehealthandcareman-
employees of Analysis Group, Inc., which received an
agementprogramforMedicarebeneficiarieswithchronicdiseaselinkedto
unrestricted grant from Robert Bosch Healthcare for this savings.HealthAff(Millwood)2011;30:1689–1697.
research. Scott J. Johnson was an employee of Analysis 13. Barnett TE, Chumbler NR, Vogel WB etal. The effectiveness of a care
Group, Inc. at the time of this research. Laurence C. Baker coordinationhometelehealthprogramforveteranswithdiabetesmellitus:
A2-yearfollow-up.AmJManagCare2006;12:467–474.
acted as a consultant to Analysis Group under the unre-
14. DarkinsA,RyanP,KobbRetal.Carecoordination/hometelehealth:The
stricted grant. systematicimplementationofhealthinformatics,hometelehealth,anddis-
Author Contributions: All authors contributed to easemanagementtosupportthecareofveteranpatientswithchroniccon-
study design; collection, management, analysis, and inter-
ditions.TelemedJEHealth2008;14:1118–1126.
15. KleinpellRM,FletcherK,JenningsBM.Patientsafetyandquality:Anevi-
pretation of data; and preparation, review, and approval
dence-basedhandbookfornurses(AHRQPublicationNo.08–0043),April
of the manuscript. All authors had full access to the data 2008. Rockville, MD: Agency for Healthcare Research and Quality [on-
in the study. Laurence C. Baker and Dendy S. Macaulay line]. Available at http://www.ahrq.gov/qual/nurseshdbk/docs/KleinpellR_
take responsibility for the integrity of the data and the RFDHE.pdfAccessedDecember6,2012.
16. LimitedDataSet(LDS)Files.CentersforMedicareandMedicaidServices
accuracy of the data analysis.
[on-line]. Available at http://www.cms.gov/LimitedDataSets/12_Standard-
Sponsor’s Role: This project was supported by Robert AnalyticalFiles.aspAccessedDecember6,2012.
Bosch Healthcare under a contract that provided for inde- 17. USDepartmentofHealthandHumanServices,HealthResourcesandSer-
pendent analysis by the authors. The role of the sponsor in vices Administration, Bureau of Health Professions. Area Resource File
(ARF). Rockville, MD: Health Resources and Services Administration;
eachphaseoftheresearchwasasfollows.DesignandCon-
2008.
duct of the Study: The sponsor requested a proposal for 18. Rosenbaum P, Rubin D. Constructing a control group using multivariate
analysis from the authors. The authors designed and pro- matchedsamplingmethodsthatincorporatethepropensityscore.AmStat
posed the study, which the sponsor accepted. The authors
1985;39:33–38.
19. Risk adjustment. Centers for Medicare and Medicaid Services [on-line].
conductedthestudy.Collection,management,analysis,and
Available at http://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSp-
interpretationofthedata:Someofthedatausedinthestudy ecRateStats/Risk_adjustment.htmlAccessedDecember6,2012.
werecollectedaspartofaCMSdemonstrationproject.The 20. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and
sponsor assisted in having these data made available to the Charlson/Deyo methods of comorbidity measurement in administrative
data.MedCare2004;42:355–360.
authors. The authors collected these and other data used in
21. Efron B, Tibshirani R. An Introduction to the Bootstrap. London:
the study and managed, analyzed, and interpreted the data. ChapmanandHall;1993.
Preparation, review, or approval of the manuscript: The 22. DiMatteo MR, Giordani PJ, Lepper HS etal. Patient adherence and
authorspreparedthemanuscript.Themanuscriptwasmade medical treatment outcomes: A meta-analysis. Med Care 2002;40:794–
811.
availabletothesponsorforcomment,andthesponsorpro-
23. Bodenheimer T, Lorig K, Holman H etal. Patient self-management of
vided comments, which the authors considered in further chronicdiseaseinprimarycare.JAMA2002;288:2469–2475.
revisions.Bycontract,theauthorshadtheauthoritytoinde- 24. Wilkinson TM, Donaldson GC, Hurst JR etal. Early therapy improves
pendentlyreviseandsubmitthemanuscript. outcomes of exacerbations of chronic obstructive pulmonary disease. Am
JRespirCritCareMed2004;169:1298–1303.
25. LakhanP,JonesM,WilsonAetal.Aprospectivecohortstudyofgeriatric
REFERENCES syndromesamongoldermedicalpatientsadmittedtoacutecarehospitals.
JAmGeriatrSoc2011;59:2001–2008.
26. YendeS,AngusDC,AliISetal.Influenceofcomorbidconditionsonlong-
1. Anderson G. Chronic care: Making the case for ongoing care. Princeton:
term mortality after pneumonia in older people. J Am Geriatr Soc
RobertWoodJohnsonFoundation;2010[on-line].Availableatwww.rwjf.
2007;55:518–525.
org/pr/product.jsp?id=50968AccessedDecember9,2011.
27. NieJX,WangL,UpshurRE.MortalityofelderlypatientsinOntarioafter
2. WagnerEH,AustinBT,DavisCetal.Improvingchronicillnesscare:Trans-
latingevidenceintoaction.HealthAff(Millwood)2001;20:64–78. hospital admission for chronic obstructive pulmonary disease. Can Respir
J2007;14:485–489.
3. Bott DM, Kapp MC, Johnson LB etal. Disease management for chroni-
28. Klersy C, De Silvestri A, Gabutti G etal. A meta-analysis of remote
cally ill beneficiaries in traditional Medicare. Health Aff (Millwood)
2009;28:86–98. monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683–
1694.
4. PeikesD,ChenA,SchoreJetal.Effectsofcarecoordinationonhospital-
29. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global
ization, quality of care, and health care expenditures among Medicare
beneficiaries:15randomizedtrials.JAMA2009;301:603–618. strategyforthediagnosis,managementandpreventionofchronicobstruc-
JAGS SEPTEMBER2013–VOL. 61, NO. 9 EFFECTSOFCAREMANAGEMENTANDTELEHEALTH 1567
tive lung disease: updated 2010 [on-line]. Available at http://www.gold- Figure S1. Distribution of propensity score for Inter-
copd.org/AccessedDecember??,2011. vention and Control participants.
30. Connors AF Jr, Dawson NV, Thomas C etal. Outcomes following acute
Table S1. List of Exclusionary Comorbidities, ICD-9
exacerbation of severe chronic obstructive lung disease. Am J Respir Crit
CareMed1996;154:959–967. Codes, and CPT Codes.
31. TakahashiPY,PecinaJL,UpatisingBetal.Arandomizedcontrolledtrial Table S2. Control county selection criteria.
oftelemonitoringinolderadultswithmultiplehealthissuestopreventhos- Table S3. ICD-9-CM diagnosis codes for disease clas-
pitalizations and emergency department visits. Arch Intern Med
sification of participants.
2012;172:773–779.
Table S4. Regression specifications.
Please note: Wiley-Blackwell is not responsible for the
content, accuracy, errors, or functionality of any support-
SUPPORTING INFORMATION
ing materials supplied by the authors. Any queries (other
Additional Supporting Information may be found in the than missing material) should be directed to the corre-
online version of this article: sponding author for the article
